A Two-Step Approach to Measurement Error in Time-Dependent Covariates in Nonlinear Mixed-Effects Models, with Application to IGF-I Pharmacokinetics

Journal of the American Statistical Association

Volumn 92, Issue 438, 1997, Pages 436-448

  Higgins, Karen M ^a   Davidian, Marie ^b   Giltinan, David M ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c GENENTECH INC   (United States)

Author keywords

Bootstrap; Empirical Bayes; Linearization; Regression calibration

Indexed keywords

EID: 0031511277     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1080/01621459.1997.10473995     Document Type: Article

References (26)

1. Beal, S. L., Boeckmann, A. J., and Sheiner, L. B. (1992), NONMEM User's Guide VI, University of California, San Francisco.
2. Beal, S. L., and Sheiner, L. B. (1982), "Estimating Population Kinetics," CRC Critical Reviews in Biomedical Engineering, 8, 195-222.
3. Beal, S. L., and Sheiner, L. B (1992), NONMEM User's Guide VIl, University of California, San Journal of the American Statistical Association, June 1997 Francisco.
4. Boeckmann, A. I., Sheiner, L. B., and Beal, S. L. (1992), NONMEM User's Guide V, University of California, San Francisco.
5. Carroll, R. J., and Ruppert, D. (1988), Transformation and Weighting in Regression, New York: Chapman and Hall.
6. Carroll, R J., Ruppert, D., and Stefanski, L. A. (1995), Measurement Error in Nonlinear Models, London: Chapman and Hall.
7. Davidian, M., and Gallant, A. R. (1992), "Smooth Nonparametric Maximum Likelihood Estimation for Population Pharmacokinetics, With Application to Quinidine," Journal of Pharmacokinetics and Biopharmaceutics, 20, 529-556.
8. Davidian, M., and Gallant, A. R. (1993), "The Nonlinear Mixed Effects Model With a Smooth Random Effects Density," Biometrika, 80, 475-488.
9. Davidian, M., and Giltinan, D. M. (1995), Nonlinear Models for Repeated Measurement Data, London: Chapman and Hall.
10. Fuller W. A. (1987), Measurement Error Models, New York: Wiley.
11. Gibaldi, M., and Perrier, D. (1982), Pharmacokinetics, New York: Marcel Dekker.
12. Laird, N. M., and Ware, J. H. (1982), "Random-Effects Models for Longitudinal Data," Biometrics, 38, 963-974.
13. Lieberman, A. A., Bukar, J., Chen, S. A., Celniker, A. C., Compton, P. G., Cook, J., Albu, J., Perlman, A. J., and Hoffman, A. R (1992), "Effects of Recombinant Human Insulin-Like Growth Factor-I (rhIGFI) on Total and Free IGF-I Concentrations, IGF-I Binding Proteins, and Glycemic Response in Humans," Journal ofClinical Endocrinology and Metabolism, 75, 30-36.
14. Lindstrom, M. J., and Bates, D. M. (1990), "Nonlinear Mixed Effects Models for Repeated Measures Data," Biometrics, 46, 673-687.
15. Mallet, A., Mentre, E, Steimer, JcL, and Lokiec, E (1988), "Nonparametric Maximum Likelihood Estimation for Population Pharmacokinetics, With Application to Cyclosporine,' Journal of Pharmacokinetics and Biopharmaceutics, 16; 31F8-327.
16. Mandema, J. w., Verotta, D., and Sheiner, L. B. (1992), "Building Population Pharmacokinetic/Pharmacodynamic Models," Journal of Pharmacokinetics and Biopharmaceutics, 20, 511-529.
17. Pinheiro, J. C, and Bates, D. M. (1995), "Mixed Effects Models, Classes and Methods for Sand S-PLUS," technical report, University of Wisconsin: Dept. of Statistics.
18. Rowland, M., and Tozer, T. N. (1995), Clinical Pharmacokinetics: Concepts and Principles (3rd ed.), Baltimore: Williams and Wilkins.
19. SAS Institute Inc. (1996), "The MIXED Procedure," in SAS/STAT Software: Changes and Enhancements through Release 6.11, Cary, NC: Author.
20. Sheiner, L. B., and Ludden, T. M. (1992), "Population Pharmacokinetics/ Pharmacodynamics," Annual Review of Pharmacological Toxicology, 32, 185-209.
21. Shi, M., Weiss, R E., and Taylor, J. M. G. (1996), "An Analysis of Paediatric CD4 Counts for Acquired Immune Deficiency Syndrome Using Flexible Random Curves," Applied Statistics, 45, 151-163.
22. Vonesh, E. F., and Carter, R L. (1992), "Mixed Effects Nonlinear Regression for Unbalanced Repeated Measures," Biometrics, 48, 1-18.
23. Wakefield, J. (1996), "The Bayesian Analysis of Population Pharmacokinetic Models," Journal of the American Statistical Association, 91, 62-75.
24. Wakefield, J., and Bennett, J. (1996), "The Bayesian Modeling of Covariates for Population Pharmacokinetic Models," Journal of the American Statistical Association, 91, 917-927. Wilton, A., Sietnieks, A., Gunnarsson, R, Berger, L., and Grahnen, A.
25. Wakefield, J., and Bennett, J (1991), "Pharmacokinetic Profile of a Recombinant Human InsulinLike Growth Factor I Given Subcutaneously in Normal Subjects," Acta Psediatrica Scandanavia, 337, 111-114.
26. Wolfinger, R (1993), "Laplace's Approximation for Nonlinear Mixed Models," Biometrika, 80, 791-795.